Teplizumab: Type 1 diabetes drug that delays the condition gets US approval

0
19

In an ongoing trial, the drug teplizumab delayed type 1 diabetes’ onset in children and adults by nearly three years, compared with placebo

Health



18 November 2022

A person with diabetes injecting insulin

A person with diabetes injecting insulin

kevajefimija/Getty Images/iStockphoto

A new…

Source link

Advertisement

LEAVE A REPLY

Please enter your comment!
Please enter your name here